Search

The Fred’s Team community reached a new milestone during the 2023 season by raising $8 million. 100% of the funds raised will go directly to cancer research at Memorial Sloan Kettering Cancer Center.

… Friday, January 19, 2024 Fred’s Team , the official running program of Memorial Sloan Kettering Cancer Center (MSK) , set a new single-season fundraising record in 2023 by raising $8 million for cancer research at MSK. This new milestone is a testament to the Fred’s Team community’s enduring commitment

Memorial Sloan Kettering Cancer Center today launched a transformative initiative to improve the quality of cancer care and the lives of cancer patients. Hartford HealthCare, a multi-hospital health care system in Connecticut, was selected as a pioneering member of the newly formed Memorial Sloan Kettering Cancer Alliance.

… Tuesday, September 17, 2013 Hartford HealthCare Selected to Be First MSK Cancer Alliance Member Memorial Sloan Kettering Cancer Center today launched a transformative initiative to improve the quality of cancer care and the lives of cancer patients. Hartford HealthCare, a multi-hospital health care system

Black adults are more likely to get colorectal cancer and die from it than any other group. Learn how Black men and women can protect themselves and why screening for colorectal cancer beginning at age 45 is so important.

… Friday, June 4, 2021 One of the cruel realities of cancer is that Black men and women are more likely to get colorectal cancer than any other racial or ethnic group in the country — and even worse, are more likely to die of the disease. Black adults and colorectal cancer Highest rate of any racial/ethnic

The combination of taselisib and fulvestrant has shown to slow the growth of cancer in post-menopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor-2 (HER2) negative, PIK3CA-mutant, inoperable, locally advanced or metastatic breast cancer. Researchers from Memorial Sloan Kettering Cancer Center (MSK) presented this data, from the SANDPIPER trial, in a press conference at the annual meeting of the American Society of Clinical Oncology. This combination of a mutant-selective PI3K inhibitor and a selective estrogen receptor degrader halted the growth of advanced breast cancer for two months longer than hormone therapy alone and decreased the chance of cancer worsening by 30 percent.

… Saturday, June 2, 2018 The combination of taselisib and fulvestrant has shown to slow the growth of cancer in post-menopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor-2 (HER2) negative, PIK3CA-mutant, inoperable, locally advanced or metastatic breast cancer.

In partnership with the Nassau County Department of Health, MSK Nassau staff equitably distributed COVID-19 vaccinations to hundreds of residents.

… Friday, April 23, 2021 Nassau County resident receives literature from MSK nurse Nassau County resident Farrah Mozawalla receives literature from MSK nurse Curt Haase prior to receiving her second dose of the COVID-19 vaccine. MSK nurse Curt Haase administers the vaccine MSK nurse Curt Haase administers

Learn what to do if you find a lump in your breast.

… Wednesday, May 29, 2024 You might know  how to check yourself for breast lumps , but do you know what to do if you find one? Janice Shen, MD , a breast medical oncologist at Memorial Sloan Kettering Cancer Center (MSK) Commack offers these recommendations. First, don’t panic if you find a lump or change

A new health policy report which will be published in the New England Journal of Medicine suggests that the swift and dramatic rise in cancer-drug spending is due to laws that keep Medicare from managing the use or price of cancer drugs. These laws limit Medicare's actions in cancer far more than they are limited in other areas of healthcare.

… Tuesday, January 27, 2009 A new health policy report suggests that the swift and dramatic rise in cancer-drug spending is due to laws that keep Medicare from managing the use or price of cancer drugs. These laws limit Medicare’s actions in cancer far more than they are limited in other areas of healthcare

… Friday, September 5, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:  Matthew Bott Joins the Lung Cancer Research Foundation Scientific Advisory Board Matthew Bott Matthew Bott, MD , thoracic surgeon, has  joined the Lung Cancer Research Foundation

Learn about the journey of Cornelius Taabazuing, a rising young scientist who recently won the Tri-Institute Breakout Award for Young Investigators at the Sloan Kettering Institute.

… Tuesday, May 25, 2021 At this year’s Convocation, which is the highlight of Memorial Sloan Kettering’s academic efforts, Sloan Kettering Institute postdoctoral fellow Cornelius Taabazuing was honored with a prestigious award — the 2021 Tri-Institutional (Tri-I) Breakout Award for Junior Investigators

MSK specialists are working to help reduce the stigma around lung cancer and smoking, helping to ensure that all patients get the best care.

… Thursday, April 17, 2025 More than half of people with lung cancer say they have been stigmatized by friends, family, and even healthcare providers at some point in their cancer journey. Other people may assume, because lung cancer is often caused by smoking, that the patient is to blame.  But as smoking